Here’s what you should know:
1. The Trump administration has yet to introduce any formal policy around drug pricing, however President Donald Trump has decreed on several occasions lowering drug prices was a major goal.
2. The Hill reports it’s unclear if the meetings have had an effect.
3. Inside Health Policy believes the Trump administration will announce it has reached a deal with the makers of insulin to lower the cost of the drug for people without insurance.
4. HHS Secretary Alex Axar said the department would like to work with pharmaceutical companies, but would take action if the industry was uncooperative.
More articles on coding, billing and collections:
Envision Healthcare to be acquired for $9.9B & more — 9 ASC company key notes
NextGen Oral Maxillofacial & Reconstructive Surgery Center now open — 3 insights
American Society of Interventional Pain Physicians recognizes Dr. W. Stephen Minore — 3 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.